Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Salmeterol

Bryan S. Adams  1 , Hoang Nguyen  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Salmeterol

Bryan S. Adams et al.
Free Books & Documents

Excerpt

Salmeterol is a medication used in the management and treatment of asthma and COPD. It is in the beta-2 adrenergic agonist class medications. This activity reviews the indications, mechanism of action, and contraindications for salmeterol as a valuable agent in treating asthma and COPD. This activity will highlight the mechanism of action, adverse event profile, and dosing pertinent for members of the interprofessional team in the treatment of patients with asthma and related conditions.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Bryan Adams declares no relevant financial relationships with ineligible companies.

Disclosure: Hoang Nguyen declares no relevant financial relationships with ineligible companies.

References

    1. D'Alonzo GE, Tolep KA. Salmeterol in the treatment of chronic asthma. Am Fam Physician. 1997 Aug;56(2):558-62. - PubMed
    1. Yawn BP, Raphiou I, Hurley JS, Dalal AA. The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2010 Jun 03;5:165-78. - PMC - PubMed
    1. Bronsky EA, Pearlman DS, Pobiner BF, Scott C, Wang Y, Stahl E. Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices. Pediatrics. 1999 Sep;104(3 Pt 1):501-6. - PubMed
    1. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child. 1992 Aug;67(8):1014-7. - PMC - PubMed
    1. Popov TA, De Niet S, Vanderbist F. Budesonide/salmeterol in fixed-dose combination for the treatment of asthma. Expert Rev Respir Med. 2016 Feb;10(2):113-25. - PubMed

Publication types

LinkOut - more resources